Decreased use of active temperature management following publication of the TTM trial

Comment

. 2017 Apr:113:e15.

doi: 10.1016/j.resuscitation.2017.02.003. Epub 2017 Feb 16.

Affiliations

¹ John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: benmillette@gmail.com.
² Wexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UK.

Comment

B H Millette et al. Resuscitation. 2017 Apr.

. 2017 Apr:113:e15.

doi: 10.1016/j.resuscitation.2017.02.003. Epub 2017 Feb 16.

¹ John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: benmillette@gmail.com.
² Wexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UK.

No abstract available

Comment on

Targeted temperature management at 33°C versus 36°C after cardiac arrest.
Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, Pellis T, Stammet P, Wanscher M, Wise MP, Åneman A, Al-Subaie N, Boesgaard S, Bro-Jeppesen J, Brunetti I, Bugge JF, Hingston CD, Juffermans NP, Koopmans M, Køber L, Langørgen J, Lilja G, Møller JE, Rundgren M, Rylander C, Smid O, Werer C, Winkel P, Friberg H; TTM Trial Investigators. Nielsen N, et al. N Engl J Med. 2013 Dec 5;369(23):2197-206. doi: 10.1056/NEJMoa1310519. Epub 2013 Nov 17. N Engl J Med. 2013. PMID: 24237006 Clinical Trial.